Crizotinib

ATC L01ED01 · 10 markets · 33 records

Crizotinib 10 markets · 33 records Forms

US 5 records · 5 strengths

250 mgcapsuleXalkori also in GB·AU·ES +4
200 mgcapsuleXalkori also in GB·AU·ES +4
150 mgcapsuleXalkori also in ES
50 mgcapsuleXalkori also in ES
20 mgcapsuleXalkori also in ES

GB 5 records · 2 strengths

250 mgcapsuleXalkori also in US·AU·ES +4
200 mgcapsuleXalkori also in US·AU·ES +4

AU 5 records · 3 strengths

250 mgcapsuleXalkori+1XALKORI crizotinib 200 mg capsule blister pack also in US·GB·ES +4 unknown
200 mgcapsuleXalkori+1XALKORI crizotinib 200 mg capsule blister pack also in US·GB·ES +4 unknown

Records without a stated strength · 1 Xalkori

ES 5 records · 5 strengths

250 mgcapsuleXalkori also in US·GB·AU +4
200 mgcapsuleXalkori also in US·GB·AU +4
150 mgcapsuleXALKORI ABRIR also in US
50 mgcapsuleXALKORI ABRIR also in US
20 mgcapsuleXALKORI ABRIR also in US

CN 4 records · 2 strengths

250 mgcapsule赛可瑞克唑替尼 also in US·GB·AU +4
200 mgcapsule赛可瑞克唑替尼 also in US·GB·AU +4

CA 2 records · 2 strengths

250 mgcapsuleXalkori also in US·GB·AU +4
200 mgcapsuleXalkori also in US·GB·AU +4

SG 2 records · 2 strengths

250 mgcapsuleXalkori also in US·GB·AU +4
200 mgcapsuleXalkori also in US·GB·AU +4

TW 2 records · 2 strengths

250 mgcapsuleXalkori+1截剋瘤膠囊250毫克 also in US·GB·AU +4
200 mgcapsuleXalkori+1截剋瘤膠囊200毫克 also in US·GB·AU +4

HK 2 records · 1 strengths

Records without a stated strength · 1 Xalkori

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Records without a stated strength · 1 Xalkori

Side-by-side table

Strength / form / release	US	GB	CA	AU	SG	CN	ES	TW	HK	EU
250 mgRecorded as: 0.25 g capsule	Xalkori	Xalkori	Xalkori	Xalkori XALKORI crizotinib 200 mg capsule blister pack	Xalkori	赛可瑞克唑替尼	Xalkori	Xalkori 截剋瘤膠囊250毫克	not recorded	not recorded
200 mgRecorded as: 0.2 g capsule	Xalkori	Xalkori	Xalkori	Xalkori XALKORI crizotinib 200 mg capsule blister pack	Xalkori	赛可瑞克唑替尼	Xalkori	Xalkori 截剋瘤膠囊200毫克	not recorded	not recorded
150 mg capsule	Xalkori	not recorded	not recorded	not recorded	not recorded	not recorded	XALKORI ABRIR	not recorded	not recorded	not recorded
50 mg capsule	Xalkori	not recorded	not recorded	not recorded	not recorded	not recorded	XALKORI ABRIR	not recorded	not recorded	not recorded
20 mg capsule	Xalkori	not recorded	not recorded	not recorded	not recorded	not recorded	XALKORI ABRIR	not recorded	not recorded	not recorded
not disclosed unknown	not recorded	not recorded	not recorded	Xalkori	not recorded	not recorded	not recorded	not recorded	Xalkori	Xalkori

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.